Trials / Sponsors / Scientific Center for Anti-infectious Drugs, Kazakhstan
Scientific Center for Anti-infectious Drugs, Kazakhstan
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | "Efesovir" (FS-1) for COVID-19, Phase 2 Covid19 | Phase 2 | 2025-12-01 |
| Completed | PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers Infections, Respiratory | Phase 1 | 2016-06-17 |
| Completed | FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis Tuberculosis, MDR | Phase 3 | 2013-12-01 |